中文

Untranslated

English
Chinese
French
German
Portuguese
Spanish
Russian
Japanese
Korean
Arabic
Irish
Greek
Turkish
Italian
Danish
Romanian
Indonesian
Czech
Afrikaans
Swedish
Polish
Basque
Catalan
Esperanto
Hindi
Lao
Albanian
Amharic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Bulgarian
Cebuano
Chichewa
Corsican
Croatian
Dutch
Estonian
Filipino
Finnish
Frisian
Galician
Georgian
Gujarati
Haitian
Hausa
Hawaiian
Hebrew
Hmong
Hungarian
Icelandic
Igbo
Javanese
Kannada
Kazakh
Khmer
Kurdish
Kyrgyz
Latin
Latvian
Lithuanian
Luxembou..
Macedonian
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Mongolian
Burmese
Nepali
Norwegian
Pashto
Persian
Punjabi
Serbian
Sesotho
Sinhala
Slovak
Slovenian
Somali
Samoan
Scots Gaelic
Shona
Sindhi
Sundanese
Swahili
Tajik
Tamil
Telugu
Thai
Ukrainian
Urdu
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
Kinyarwanda
Tatar
Oriya
Turkmen
Uyghur

More Language

86-21-64556180

cpd-service@caerulumpharma.com

Home
E pili ana iā mākou
Nā huahana
Nā hoʻonā
Nā kumuwaiwai
- Hiki ke hoʻoili ʻia
- Hale kiʻi kiʻi
FAQs
Kāhea iā mā˚ou

Home
Nā huahana
Nā moleke olaola
ʻO nā mea ʻē aʻe
AHR

Nā Māhele Huahana

Atineoplastic
- ACC
- Adenosine A2A
- ALK
- ʻO ka mea hoʻopaneʻe hoʻokipa Androgen
- Mea hoʻoulu apoptosis
- ATR
- AXL
- BCl2-BH4
- Bcr-Abl
- BRAF
- BTK
- CDK
- Chk1
- CYP17
- DNA alkylating agent
- EED
- EGFR
- EP4
- ER
- FAK
- FGFR
- FLT3
- Glutaminase
- MAKEMAKE WAU
- IRA
- KIT
- LXR
- MDM2
- MEK
- MET
- Nrf2
- P90RSK
- P97
- PAKS
- PARP
- PI3K
- Plk-1
- SMYD2
- SRC
- TOPK
- VEGFR
Nā lāʻau hypoglycemic
- DPP-4
- SGLT-1
- SGLT-2
ʻO nā mea ʻē aʻe
- 5HT
- AMPK
- Arginase
- CRF-1
- CXCR2
- FLAP
- FXR
- GABA
- Mea hoʻoulu ʻia
- GR
- JAK
- LABA
- mAChRs
- NF-κB
- NRTI
- PPAR
- RIP1
- S1PR
- SGC
- SYK
- α2δ-1
- αIIbβ3
- β2-adrenoceptor
- σ1

AHR

CAT #	Inoa Huahana	wehewehe
CPD3504	BAY-218

,

Kāhea iā mā˚ou

Helu 401, 4th Floor, Hale 6, Quwu Road 589, Minhang District, 200241 Shanghai, Kina
86-21-64556180
Ma loko o Kina:
sales-cpd@caerulumpharma.com
International:
cpd-service@caerulumpharma.com

Ninau

No nā nīnau e pili ana i kā mākou huahana, e ʻoluʻolu e waiho i kāu leka uila me mākou a e hoʻopili mākou i loko o 24 mau hola.Ninau

Nuhou Hou

Loaʻa iā AstraZeneca ka hoʻoikaika kānāwai no nā lāʻau lapaʻau oncology

Loaʻa iā AstraZeneca ka hoʻonui hoʻoponopono no...

Ua loaʻa iā AstraZeneca kahi hoʻonui pālua no kāna kōpili oncology i ka Pōʻalua, ma hope o ka ʻae ʻana o nā regulators US a me ʻEulopa i nā hoʻouna kānāwai no kāna mau lāʻau lapaʻau, ʻo ka hana mua i ka lanakila ʻana i kēia mau lāʻau lapaʻau. ...

ʻO 7 ʻoi loa ma ka noiʻi lāʻau lapaʻau ma 2018

ʻO 7 ʻoi loa i ka noiʻi lāʻau lapaʻau I...

Ma lalo o ka piʻi nui ʻana o ka hoʻokūkū e hoʻokūkū i kahi ʻenehana paʻakikī a me ka ʻenehana, pono e hoʻomau nā ʻoihana lāʻau lapaʻau a me biotech i kā lākou papahana R&D e noho i mua ...

ARS-1620: He mea hoʻohiki hou no nā maʻi maʻi KRAS-mutant

ARS-1620: He mea hoʻohiki hou no K...

Wahi a kahi noiʻi i paʻi ʻia ma Cell, ua hoʻomohala nā mea noiʻi i kahi inhibitor kūikawā no KRASG12C i kapa ʻia ʻo ARS-1602 i hoʻoulu i ka regression tumor i nā ʻiole. "Ke hāʻawi nei kēia haʻawina i nā hōʻike vivo e hiki ke lilo i mutant KRAS ...

Loaʻa iā AstraZeneca ka hoʻonui hoʻoponopono no...

Ua loaʻa iā AstraZeneca kahi hoʻonui pālua no kāna kōpili oncology i ka Pōʻalua, ma hope o ka ʻae ʻana o nā regulators US a me ʻEulopa i nā hoʻouna kānāwai no kāna mau lāʻau lapaʻau, ʻo ka hana mua i ka lanakila ʻana i kēia mau lāʻau lapaʻau. ...

ʻO 7 ʻoi loa i ka noiʻi lāʻau lapaʻau I...

Ma lalo o ka piʻi nui ʻana o ka hoʻokūkū e hoʻokūkū i kahi ʻenehana paʻakikī a me ka ʻenehana, pono e hoʻomau nā ʻoihana lāʻau lapaʻau a me biotech i kā lākou papahana R&D e noho i mua ...

FAQs
Hiki ke hoʻoili ʻia
Kāhea iā mā˚ou

Hoʻouna leka uila

QR Code

x

WhatsApp kamaʻilio pūnaewele!

TOP

Close

Previous Next

Previous Maximize